Sign Out
For the reduction of elevated total and LDL-cholesterol levels in patients with primary hypercholesterolemia (type IIa and IIb), when the response to diet and other nonpharmacological measures alone has been inadequate. Lovastin may be useful to reduce elevated LDL-cholesterol levels in patients with combined hypercholesterolemia and hypertriglyceridemia.
Before instituting therapy with Lovastin, an attempt should be made to control hypercholesterolemia with appropriate diet, exercise, weight reduction in obese patients.
